Pharmafile Logo

Gazyvo

- PMLiVE

NICE gives nod to blood cancer drug Gazyvaro

Roche’s leukaemia drug to be used in combination with chemotherapy

National Institute for Health and Care Excellence NICE logo

NICE denies Roche cancer drug due to ‘data uncertainties’

Unable to recommend Gazyvaro for untreated chronic lymphocytic leukaemia

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links